Turner Christopher Durant Insider Trading Activity
Turner Christopher Durant has been net-selling over the last 12 months with 0 purchases and 7 sales across 1 company.
NUVL is the most-traded position with 7 trades. The largest single transaction was a sale of NUVL for $189K on Jan 5, 2026.
Performance Scorecard
Forward stock performance after each transaction by Turner Christopher Durant. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -6.0% | 0% | 7 |
| 90 days | — | -6.5% | 0% | 7 |
| 120 days | — | -5.4% | 0% | 7 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersNUVL · Nuvalent, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Turner Christopher Durant bought and sold NUVL.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| Jan 6, 2026 | NUVL | Sell | 1,321 | $96.75 | $128K | Chief Medical Officer |
| Jan 6, 2026 | NUVL | Sell | 1,635 | $97.33 | $159K | Chief Medical Officer |
| Jan 6, 2026 | NUVL | Sell | 225 | $98.40 | $22K | Chief Medical Officer |
| Jan 5, 2026 | NUVL | Sell | 871 | $96.06 | $84K | Chief Medical Officer |
| Jan 5, 2026 | NUVL | Sell | 317 | $98.52 | $31K | Chief Medical Officer |
| Jan 5, 2026 | NUVL | Sell | 1,119 | $96.85 | $108K | Chief Medical Officer |
| Jan 5, 2026 | NUVL | Sell | 1,929 | $97.96 | $189K | Chief Medical Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| NUVL | Nuvalent, Inc. | 7 | $721K |
Other insiders at Nuvalent, Inc.
6 other tracked filers at NUVL.